Skip to main content
RVTY logo

RVTY · Revvity, Inc.

Track RVTY — free
Market Cap
$14.58B
Shares
111.59M

RVTY metrics

89 of 114 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$130.63
Market cap
$14.58B

Price action

19 metrics
Price change (1W)
+0.7%
Price change (30D)
+14.3%
Price change (3M)
+27.6%
Price change (6M)
+35.3%
Price change (YTD)
+35.0%
Price change (1Y)
+56.7%
Trailing year
Price change (5Y)
-31.4%
52-week high
$130.94
52-week low
$82.26
Change from 52-week high
-0.2%
Change from 52-week low
+58.8%
Annualized volatility
37.8%
Beta
1.3
RSI (14D)
68.6
Price vs SMA 50
+12.6%
Price vs SMA 200
+27.9%
Avg volume (3M)
1.50M
Relative volume
1.2
Average dollar volume
$171.17M

Company

3 metrics
Sector
Healthcare
Industry
Diagnostics & Research
Shares outstanding
111.59M

Valuation

12 metrics
P / E (TTM)
62.5
Trailing earnings · reciprocal yield 1.6%
PEG ratio
28.8
EV / revenue
EV / EBITDA
EV / EBIT
P / sales
5.0×
reciprocal yield 20.0%
P / book
2.0
reciprocal yield 49.6%
FCF yield
3.8%
TTM · current market cap
Buyback yield
3.3%
P / FCF
26.1
reciprocal yield 3.8%
P / operating cash flow
23.2
reciprocal yield 4.3%
Earnings yield
1.6%

Historical valuation

8 metrics
P / E historical average (3Y)
42.5×
reciprocal yield 2.4%
P / E historical average (5Y)
34.9×
reciprocal yield 2.9%
EV / revenue historical average (3Y)
5.4×
reciprocal yield 18.6%
EV / revenue historical average (5Y)
5.2×
reciprocal yield 19.4%
EV / EBIT historical average (3Y)
37.9×
reciprocal yield 2.6%
EV / EBIT historical average (5Y)
32.8×
reciprocal yield 3.0%
EV / EBITDA historical average (3Y)
EV / EBITDA historical average (5Y)

Dividends & buybacks

7 metrics
Dividend yield
0.2%
Trailing 12 months
Payout ratio
13.4%
Shareholder yield
3.5%
Dividend / share (TTM)
$0.28
Dividend growth YoY
+0.0%
Dividend growth streak
Last ex-dividend
2026-07-17

Earnings calendar

2 metrics
Next earnings
Last earnings
2026-08-04

Profitability

9 metrics
Gross margin
Operating margin
12.3%
Trailing 12 months
Net margin
8.2%
Gross profit (TTM)
$1.99B
Operating profit (TTM)
$358.85M
Net income (TTM)
$237.55M
Trailing 12 months
Diluted EPS (TTM)
$2.09
FCF margin
19.2%
Effective tax rate
9.0%

Per share

11 metrics
Revenue per diluted share (TTM)
Gross profit per diluted share (TTM)
Operating profit per diluted share (TTM)
EBITDA per diluted share (TTM)
Net income per diluted share (TTM)
Operating cash flow per diluted share (TTM)
Free cash flow per diluted share (TTM)
Capital expenditures per diluted share (TTM)
R&D per diluted share (TTM)
Stock compensation per diluted share (TTM)
Book value per share
$13.92

Growth

11 metrics
Revenue growth YoY
+1.3%
Year over year
Net income growth YoY
-3.9%
Revenue (TTM)
$2.91B
Trailing 12 months
EPS growth YoY
+2.2%
Shares change YoY
-5.0%
Year over year · fewer shares
Revenue CAGR (3Y)
-4.8%
Revenue CAGR (5Y)
-5.5%
EPS CAGR (3Y)
-22.8%
EPS CAGR (5Y)
-20.4%
FCF CAGR (3Y)
-5.0%
FCF CAGR (5Y)
-9.3%

Quality

14 metrics
Return on equity
3.3%
Return on assets
2.0%
Debt / equity
0.4
Current ratio
1.8
EBITDA (TTM)
$771.08M
Free cash flow (TTM)
$558.11M
Quick ratio
1.5
Interest coverage
3.8
Net debt / EBITDA
Return on invested capital
Trailing 12 months
Net cash
Latest balance sheet
Cash & equivalents
$1.02B
Total assets
$12.05B
Total debt
$3.21B

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$627.63M
Capital expenditures (TTM)
$69.52M
R&D (TTM)
$215.83M
SG&A (TTM)
$1.03B
Stock compensation (TTM)
R&D / revenue
7.4%
Stock compensation / revenue

Ownership (13F)

3 metrics
13F filers
544
13F filer change QoQ
+37
Institutional ownership
102.2%

Short interest

3 metrics
Short interest
5.7%
Latest settlement · 4.1 days to cover
Days to cover
4.1d
Short-squeeze score
65 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$9,306
Insider-sentiment score

Risk flags

1 metrics
Going concern
Key facts CIK 31791 CUSIP 714046109 13F (30d) 339 filings 319 filers Visit website Investor relations